GlaxoSmithKline
GSK
#216
Rank
C$133.33 B
Marketcap
C$65.82
Share price
-1.89%
Change (1 day)
33.65%
Change (1 year)

GlaxoSmithKline (GSK) - Total assets

Total assets on the balance sheet as of September 2025 : C$114.13 Billion

According to GlaxoSmithKline's latest financial reports the company's total assets are C$114.13 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

GlaxoSmithKline - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$107.07 B7.4%
2023-12-31C$99.70 B0.98%
2022-12-31C$98.73 B-27.44%
2021-12-31C$136.07 B-2.65%
2020-12-31C$139.78 B2.42%
2019-12-31C$136.48 B35.94%
2018-12-31C$100.40 B4.8%
2017-12-31C$95.80 B-2.21%
2016-12-31C$97.96 B-10.83%
2015-12-31C$109.87 B49.59%
2014-12-31C$73.44 B-0.61%
2013-12-31C$73.89 B10.84%
2012-12-31C$66.66 B2.65%
2011-12-31C$64.94 B-0.33%
2010-12-31C$65.16 B-10.71%
2009-12-31C$72.97 B3.96%
2008-12-31C$70.19 B14.14%
2007-12-31C$61.50 B5.57%
2006-12-31C$58.25 B6.71%
2005-12-31C$54.59 B4.58%
2004-12-31C$52.20 B-6.04%
2003-12-31C$55.56 B-1.73%
2002-12-31C$56.54 B11.44%
2001-12-31C$50.73 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AstraZeneca
AZN
C$158.42 B 38.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$288.91 B 153.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$179.30 B 57.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$148.50 B 30.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$210.83 B 84.72%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
C$55.16 B-51.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
C$1.31 B-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA